JPS5811871B2 - Piperidylbenzimidazole - Google Patents
PiperidylbenzimidazoleInfo
- Publication number
- JPS5811871B2 JPS5811871B2 JP50061608A JP6160875A JPS5811871B2 JP S5811871 B2 JPS5811871 B2 JP S5811871B2 JP 50061608 A JP50061608 A JP 50061608A JP 6160875 A JP6160875 A JP 6160875A JP S5811871 B2 JPS5811871 B2 JP S5811871B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- fluorobenzoyl
- alkyl group
- melting point
- recrystallized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- JUYQSMXGDBGGSX-UHFFFAOYSA-N 2-piperidin-1-yl-1h-benzimidazole Chemical compound C1CCCCN1C1=NC2=CC=CC=C2N1 JUYQSMXGDBGGSX-UHFFFAOYSA-N 0.000 title claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 150000001450 anions Chemical class 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000005059 halophenyl group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- 239000013078 crystal Substances 0.000 description 25
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 239000000203 mixture Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 11
- -1 2-phenethyl group Chemical group 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 10
- 239000005977 Ethylene Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000000921 elemental analysis Methods 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000006243 carbonyl protecting group Chemical group 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229960001252 methamphetamine Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 1
- FGWREHFONONYQE-UHFFFAOYSA-N 1H-benzimidazol-3-ium-2-thiol chloride Chemical compound Cl.N1C(NC2=C1C=CC=C2)=S FGWREHFONONYQE-UHFFFAOYSA-N 0.000 description 1
- OCKJFOHZLXIAAT-UHFFFAOYSA-N 2-methylsulfanyl-1h-benzimidazole Chemical compound C1=CC=C2NC(SC)=NC2=C1 OCKJFOHZLXIAAT-UHFFFAOYSA-N 0.000 description 1
- 125000004924 2-naphthylethyl group Chemical group C1=C(C=CC2=CC=CC=C12)CC* 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003354 anti-apomorphinic effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- JYZIHLWOWKMNNX-UHFFFAOYSA-N benzimidazole Chemical compound C1=C[CH]C2=NC=NC2=C1 JYZIHLWOWKMNNX-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- GHXZPUGJZVBLGC-UHFFFAOYSA-N iodoethene Chemical group IC=C GHXZPUGJZVBLGC-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical group CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000004707 phenolate Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- RZWQDAUIUBVCDD-UHFFFAOYSA-M sodium;benzenethiolate Chemical compound [Na+].[S-]C1=CC=CC=C1 RZWQDAUIUBVCDD-UHFFFAOYSA-M 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000003548 thiazolidines Chemical class 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は一般式(I)
(式中Arはハロフェニル基を、Qは−CH(Ar)−
基又はカルボニル基を、R1は水素原子、直鎖状もしく
は分枝状低級アルキル基、アラルキル基、ベンゾイル低
級アルキル基、シアノ低級アルキル基、低級アルキニル
基、アリール基或はヒドロキシ低級アルキル基を示す。Detailed Description of the Invention The present invention is based on the general formula (I) (wherein Ar represents a halophenyl group and Q represents -CH(Ar)-
group or carbonyl group, R1 represents a hydrogen atom, a linear or branched lower alkyl group, an aralkyl group, a benzoyl lower alkyl group, a cyano lower alkyl group, a lower alkynyl group, an aryl group or a hydroxy lower alkyl group.
)であられされる新規ピペリジルベンズイミダゾール誘
導体又はその塩類の製造法に関する。) A method for producing a novel piperidylbenzimidazole derivative or its salt.
式(I)の化合物は式(■)
(式中ArおよびR1は前述のとおり、Qlは−CH(
Ar)一基、カルボニル基或は保護されたカルボニル基
を、R2はアルキル基、アラルキル基を、X−はアニオ
ンを示す)であられされるピペリジニウム塩を加熱する
かもしくは塩基で処理し、必要に応じて加水分解するこ
とによって製造することが出来る。The compound of formula (I) has the formula (■) (where Ar and R1 are as described above, and Ql is -CH(
Ar) A piperidinium salt having one group, a carbonyl group or a protected carbonyl group, R2 is an alkyl group or an aralkyl group, and X- is an anion is heated or treated with a base, and if necessary It can be produced by hydrolysis according to the requirements.
ここで置換基塩の定義に使用したアルキル基又はアラル
キル基としては、例えばメチル基、エチル基、イソプロ
ピル基、イソブチル基、ベンジル基、2−フェネチル基
、2−ナフチルメチル基、2−ナフチルエチル基などが
挙げられる。Examples of the alkyl group or aralkyl group used in the definition of the substituent salt include methyl group, ethyl group, isopropyl group, isobutyl group, benzyl group, 2-phenethyl group, 2-naphthylmethyl group, 2-naphthylethyl group. Examples include.
またX−のアニオンとしては、例えば塩素、臭素、ヨウ
素などのハロゲン、水酸基、硫酸基およびアセトキシ、
メタンスルホニルオキシ、パラトルエンスルホニルオキ
シなどのアニオンを意味する。Examples of the anion of X- include halogens such as chlorine, bromine, and iodine, hydroxyl groups, sulfate groups, acetoxy,
It means an anion such as methanesulfonyloxy or paratoluenesulfonyloxy.
又、「保護されたカルボニル基」としては、例えばジメ
チルケタール、エチレンケタール等のケタール類、チオ
ケタール類、ヘミチオケタール類、チアゾリジン類、エ
ノールエーテル類、エノールエステル類、シッフ塩基、
オキシム等があり、中でも取扱いの容易さなどからエチ
レンケタールが好適に用いられる。Examples of the "protected carbonyl group" include ketals such as dimethyl ketal and ethylene ketal, thioketals, hemithioketals, thiazolidines, enol ethers, enol esters, Schiff bases,
There are oximes and the like, among which ethylene ketal is preferably used because of its ease of handling.
本発明のピペリジニウム塩の分解反応は0〜250℃に
加熱するか、あるいは適当な塩基と接触させることによ
って行なうことが出来る。The decomposition reaction of the piperidinium salt of the present invention can be carried out by heating it to 0 to 250°C or by contacting it with an appropriate base.
この場合、反応温度は低温でもよいが、反応温度を上昇
させることにより反応を有効に促進させることが出来る
。In this case, the reaction temperature may be low, but the reaction can be effectively promoted by increasing the reaction temperature.
この発明の反応は無溶媒でも行なわれるが、水、アルコ
ール類、石油類、芳香族炭化水素類、エーテル類、アセ
トニトリル、ジメチルホルムアミド、アセトン、ハロゲ
ン化炭化水素類あるいはこれらの混合物などの反応に関
与しない溶媒を使用することも出来る。Although the reaction of this invention can be carried out without a solvent, the reaction may be performed using water, alcohols, petroleum, aromatic hydrocarbons, ethers, acetonitrile, dimethylformamide, acetone, halogenated hydrocarbons, or mixtures thereof. It is also possible to use solvents that do not.
また好適に用いられる塩基としては、例えば水酸化ナト
リウム、水酸化カリウムなどの金属水酸化物、水素化ナ
トリウムなどの金属水素化物、ナトリウムエチラート、
カリウム第三ブチラードなどの金属アルコラード、ナト
リウムフェノラート、ナトリウムチオフェノラートなど
の金属フェノラートあるいはチオフェノラート、酸化銀
、ヨウ化メチルマグネシウムなどのグリニヤール試薬な
どがある。Examples of suitable bases include metal hydroxides such as sodium hydroxide and potassium hydroxide, metal hydrides such as sodium hydride, sodium ethylate,
Examples include metal alcoholades such as potassium tert-butyralate, metal phenolates or thiophenolates such as sodium phenolate and sodium thiophenolate, and Grignard reagents such as silver oxide and methylmagnesium iodide.
反応終了後は通常の手法によって目的物を単離すること
が出来る。After the reaction is completed, the target product can be isolated by conventional techniques.
式(■)の原料化合物でカルボニル基が保護されている
場合、処理手段によっては反応と同時にカルボニルの保
護基がはずれることもあるが、保護基がはずれないとき
は公知の常法、例えば稀鉱酸で加水分解することによっ
てカルボニルの保護基を除去することも出来る。When the carbonyl group is protected in the raw material compound of formula (■), the carbonyl protecting group may be removed at the same time as the reaction depending on the treatment method, but if the protecting group cannot be removed, a known conventional method such as rare mineral The carbonyl protecting group can also be removed by hydrolysis with acid.
なお本発明の方法で製造される化合物(■)は塩酸、硫
酸等の無機酸又は酢酸、クエン酸等の有機酸と反応させ
ることによって治療学的に有用な酸付加塩に変えること
が出来る。The compound (■) produced by the method of the present invention can be converted into a therapeutically useful acid addition salt by reacting with an inorganic acid such as hydrochloric acid or sulfuric acid or an organic acid such as acetic acid or citric acid.
なお、式(■)の化合物でRが水素原子の化合物は2−
ベンズイミダシリンチオン型と互変異性の関係にある。In addition, the compound of formula (■) in which R is a hydrogen atom is 2-
It has a tautomeric relationship with the benzimidacylinthion type.
本発明によって製造される弐〇)の化合物は興味ある薬
理作用を有する。The compound 2) produced according to the present invention has interesting pharmacological action.
例えば顕著な自発運動抑制作用、メタンフェタミン群居
毒性抑制作用、抗メタンフエタミン作用、条件回避反応
抑制作用、抗アポモルヒネ作用を示し、医薬特に向精神
薬として有用な性質を有する。For example, it exhibits remarkable locomotor activity suppressing activity, methamphetamine group toxicity suppressing effect, anti-methamphetamine effect, conditioned avoidance response suppressing effect, and anti-apomorphine effect, and has properties useful as a medicine, especially as a psychotropic drug.
例えば本発明に係わる代表化合物の1つである1 −(
1−(3−(4−フルオロベンゾイル)プロピル) −
4−ヒヘI)’)ル〕−2−メルカプトベンズイミダゾ
ールの薬理効果を示せば下記の通りである。For example, 1-(
1-(3-(4-fluorobenzoyl)propyl) -
The pharmacological effects of 4-hiheI)')-2-mercaptobenzimidazole are as follows.
尚、本発明の原料化合物は新規化合物であり例えば下記
する参考例の方法で容易に製することが出来る。Incidentally, the raw material compound of the present invention is a new compound and can be easily produced, for example, by the method of the following reference example.
参考例 1
4−(2−=トロアニIJ/)−1−エチルヒヘリシン
5001vと3−(4−フルオロベンシイノリプロピル
ヨード・エチレンケタール675〜および水酸化ナトリ
ウム80〜を水50m1に加え、攪拌下3時間加熱還流
する。Reference Example 1 5001v of 4-(2-=Troani IJ/)-1-ethylhyhelicine, 675~ of 3-(4-fluorobencyinolipropyl iodo ethylene ketal) and 80~ of sodium hydroxide were added to 50ml of water, and the mixture was stirred for 3 hours. Heat to reflux.
反応後濃縮乾固し、ベンゼンを加え結晶化、メタノール
から再結晶すると、1−エチル−1−(3−(4−フル
オロベンゾイル)プロピル)−41−(2−ニトロアニ
リノ)ピペリジン・エチレンケタールヨウ化物の黄色の
結晶を得る。After the reaction, it was concentrated to dryness, crystallized by adding benzene, and recrystallized from methanol to obtain 1-ethyl-1-(3-(4-fluorobenzoyl)propyl)-41-(2-nitroanilino)piperidine ethylene ketal iodide. yellow crystals are obtained.
融点244〜246°C(分解)。元素分析値 C2,
H33FIN304に対して計算値:C51,28,H
5,68,H7,18実測値:C51,24,H5,8
3,H7,02上述のようにして得られた1−エチル−
1−(3−(4−フルオロベンゾイル)プロピル〕−4
−(2−ニトロアニリノ)ピペリジン・エチレンケター
ルヨウ化物1.2gをメタノールlQ9m1中、ラネー
ニッケル2mlとともに接触還元し、水素の吸収が終っ
た後、触媒を濾去、濃縮、ベンゼンを加えて結晶化、メ
タノールから再結晶すると4−(2−アミノアニリノ)
−1−エチル−1−〔3=(4−フルオロベンゾイル)
プロピル〕ヒペリジン・エチレンケタールヨウ化物の結
晶を得る。Melting point 244-246°C (decomposed). Elemental analysis value C2,
Calculated value for H33FIN304: C51,28,H
5,68,H7,18 Actual value: C51,24,H5,8
3,H7,02 1-ethyl- obtained as described above
1-(3-(4-fluorobenzoyl)propyl)-4
1.2 g of (2-nitroanilino)piperidine ethylene ketal iodide was catalytically reduced in 9 ml of methanol with 2 ml of Raney nickel, and after hydrogen absorption was completed, the catalyst was filtered off, concentrated, crystallized by adding benzene, and methanol When recrystallized from 4-(2-aminoanilino)
-1-ethyl-1-[3=(4-fluorobenzoyl)
Obtain crystals of [propyl]hyperidine ethylene ketal iodide.
融点215〜216°C(分解)。元素分析値 C,、
H3,FIN302に対して計算値: C54,06、
H6,35、H7,59実測値: C53,89、H6
,41、H7,74上述のようにして得られた4−(2
−アミノアニリノ)−1−エチル−1−(3−(4−フ
ルオロヘンソイル)フロビル〕ヒペリジン・エチレンケ
タールヨウ化物1.10.9および水酸化カリウム22
5〜、二硫化炭素305mg、エタノール5mlおよび
水0.5m幼混液全混液全混液中で3時間反応する。Melting point 215-216°C (decomposed). Elemental analysis value C,,
Calculated value for H3, FIN302: C54,06,
H6,35, H7,59 actual measurement value: C53,89, H6
, 41, H7, 74 4-(2
-aminoanilino)-1-ethyl-1-(3-(4-fluorohensoyl)furovir)hyperidine ethylene ketal iodide 1.10.9 and potassium hydroxide 22
5~, 305 mg of carbon disulfide, 5 ml of ethanol, and 0.5 ml of water are reacted for 3 hours in a total mixture of the infant mixture.
反応後エーテルを加え粗結晶を得、結晶をエーテルおよ
び二硫化炭素で洗う。After the reaction, ether is added to obtain crude crystals, and the crystals are washed with ether and carbon disulfide.
メタノールから再結晶すると1−〔1−エチル−1−(
3−〔4−フルオロベンシイノリプロピル)−4−ピペ
リジルコ−2−メルカプトベンズイミダゾール・エチレ
ンケタールヨウ化物を得る。When recrystallized from methanol, 1-[1-ethyl-1-(
3-[4-fluorobencyinolipropyl)-4-piperidylco-2-mercaptobenzimidazole ethylene ketal iodide is obtained.
融点219〜221℃(分解)。Melting point 219-221°C (decomposed).
元素分析値 C76H33FIN302Sに対して計算
値:C52,26,H5,57,H7,03実測値:C
52,11、H5,50,H7,12参考例 2
参考例1で得られた1−〔1−エチル−1−(3−(4
−フルオロベンシイノリプロピル〕−4−ピペリジルコ
−2−メルカプトベンズイミダゾール・エチレンケター
ルヨウ化物をエタノールに溶解し、塩酸で加水分解し、
1−(1−エチル−(3−(4−フルオロベンゾイル)
プロピルクー4−ピペリジルクー2−メルカプトベンズ
イミダゾールヨウ化物を得る。Elemental analysis value Calculated value for C76H33FIN302S: C52,26, H5,57, H7,03 Actual value: C
52,11, H5,50, H7,12 Reference Example 2 1-[1-ethyl-1-(3-(4
-fluorobencyinolipropyl]-4-piperidylco-2-mercaptobenzimidazole ethylene ketal iodide was dissolved in ethanol and hydrolyzed with hydrochloric acid,
1-(1-ethyl-(3-(4-fluorobenzoyl)
Propyl-4-piperidyl-2-mercaptobenzimidazole iodide is obtained.
融点259〜265°C(分解)。Melting point 259-265°C (decomposition).
元素分析値 C24H29FIN30Sに対して計算値
:C52,08,H5,28,H7,59実測値:C5
1,81、H5,21、H7,46参考例 3
参考例1で得られた1−〔1−エチル−1−(3−(4
−フルオロヘンソイル)プロピルクー4−ピペリジルコ
−2−メルカプトベンズイミダゾール・エチレンケター
ルヨウ化物598Tn9および水酸化ナトリウム80〜
を水50dおよびメタノール50m1の溶液に加え、室
温で攪拌下、ジメチル硫酸164mgを3時間かかつて
満願する。Elemental analysis value Calculated value for C24H29FIN30S: C52,08, H5,28, H7,59 Actual value: C5
1,81, H5,21, H7,46 Reference Example 3 1-[1-ethyl-1-(3-(4
-Fluorohensoyl)propylcou 4-piperidylco-2-mercaptobenzimidazole ethylene ketal iodide 598Tn9 and sodium hydroxide 80~
was added to a solution of 50 d of water and 50 ml of methanol, and 164 mg of dimethyl sulfate was added thereto for 3 hours while stirring at room temperature.
後2時間加熱還流。After that, heat under reflux for 2 hours.
反応後濃縮し、これに50mJのクロロホルムを加えて
3回抽出。After the reaction, it was concentrated, and 50 mJ of chloroform was added thereto for extraction three times.
濃縮乾固。残渣をメタノールから再結晶し、1−(1−
エチル−1−(3−(4−フルオロベンゾイル)プロピ
ルクー4−ピペリジルコ−2−メチルチオベンズイミダ
ゾールヨウ化物の結晶を得る。Concentrate to dryness. The residue was recrystallized from methanol to give 1-(1-
Crystals of ethyl-1-(3-(4-fluorobenzoyl)propyl-4-piperidyl-2-methylthiobenzimidazole iodide are obtained).
融点248〜251℃(分解)。Melting point 248-251°C (decomposition).
元素分析値 C27H3,FIN3O2Sに対して計算
値:C53,03,H5,77、H6,87実測値:C
52,91、H5,69,H6,85参考例 4
強塩基性陰イオン交換脂ダイアイオンPA−308(ク
ロル型)30mlを充填した樹脂塔に20%−酢酸ナト
リウム水溶液を流下し、水洗したのち、メタノールでよ
く洗い、参考例1で得られた1−〔1−エチル−1−(
3−(4−フルオロベンソイル)フロビル〕−4−ピペ
リジル〕−2−メルカプトベンズイミダゾール・エチレ
ンケタールヨウ化物550m9をメタノール450m1
!に溶解し流下する。Elemental analysis value Calculated value for C27H3, FIN3O2S: C53,03, H5,77, H6,87 Actual value: C
52,91, H5,69, H6,85 Reference Example 4 A 20% aqueous sodium acetate solution was poured into a resin tower filled with 30 ml of strongly basic anion exchange resin Diaion PA-308 (chlor type), and after washing with water. , thoroughly washed with methanol, 1-[1-ethyl-1-(
550 m9 of 3-(4-fluorobenzoyl) furobil]-4-piperidyl]-2-mercaptobenzimidazole ethylene ketal iodide was added to 450 m1 of methanol.
! It dissolves in water and flows down.
さらにメタノール200Tnlを流下させ、その流下液
を濃縮。Furthermore, 200 Tnl of methanol was allowed to flow down, and the flowing liquid was concentrated.
メタノールより再結晶すると1−〔1−エチル−1−(
3−(4−フルオロベンゾイル)プロピルシー4−ピペ
リジルコ−2−メルカプトベンズイミダゾール
ケタール・アセテートの無色の結晶を得る。When recrystallized from methanol, 1-[1-ethyl-1-(
Colorless crystals of 3-(4-fluorobenzoyl)propyl-4-piperidylco-2-mercaptobenzimidazole ketal acetate are obtained.
融点183、5〜185℃(分解)。Melting point 183, 5-185°C (decomposition).
元素分析値 C28H36FN304Sに対して計算値
:C63,49、H6,85、H7,93実測値:C6
3,26、H6,79,H7,82実施例 1
1−〔1−エチル−1−(3−(4−フルオロベンゾイ
ル)プロピル)−4−ピペリジルシー2−メルカプトベ
ンズイミダゾール・エチレンケタールヨウ化物1.21
を157m9のカリウムと407nlの第三級ブタノー
ルの溶液に加え攪拌下2時間加熱還流する。Elemental analysis value Calculated value for C28H36FN304S: C63,49, H6,85, H7,93 Actual value: C6
3,26, H6,79, H7,82 Example 1 1-[1-ethyl-1-(3-(4-fluorobenzoyl)propyl)-4-piperidylcy 2-mercaptobenzimidazole ethylene ketal iodide 1 .21
was added to a solution of 157 m9 of potassium and 407 nl of tertiary butanol, and the mixture was heated under reflux for 2 hours with stirring.
反応後濃縮、−担メタノール中塩酸酸性とし10分間還
流する。After the reaction, the mixture was concentrated, acidified with hydrochloric acid in supported methanol, and refluxed for 10 minutes.
後10%炭酸ナトリウム水溶液を加え50m1のクロロ
ホルム3回抽出。Then, add 10% aqueous sodium carbonate solution and extract 3 times with 50 ml of chloroform.
無水硫酸すl−’Jウムで乾燥し、濃縮する。析出物を
濾取、アセトンより再結晶すると1−(1−(3−(4
−フルオロベンゾイル)プロピルシー4−ピペリジルコ
−2−メルカプトベンズイミダゾールの無色の結晶を得
る。Dry with anhydrous sodium sulfate and concentrate. The precipitate was collected by filtration and recrystallized from acetone to give 1-(1-(3-(4
-fluorobenzoyl)propylcy 4-piperidylco-2-mercaptobenzimidazole colorless crystals are obtained.
融点201〜203℃。Melting point: 201-203°C.
元素分析値C22H24FN30Sに対して計算値二C
66、47,H6,09,N10.57実測値:C66
、53,H6,21、N10.49これをエタノールに
溶解し、塩化水素飽和エタノールを加え濃縮、メタノー
ルから再結晶すると1−(1−(3−(4−フルオロベ
ンゾイル)プロピル)−4−ピペリジルコ−2−メルカ
プトベンズイミダゾール塩酸塩の無色プリズム晶を得る
。Calculated value 2C for elemental analysis value C22H24FN30S
66, 47, H6, 09, N10.57 Actual value: C66
, 53, H6,21, N10.49 Dissolve this in ethanol, add hydrogen chloride saturated ethanol, concentrate, and recrystallize from methanol to obtain 1-(1-(3-(4-fluorobenzoyl)propyl)-4-piperidylco - Obtain colorless prism crystals of 2-mercaptobenzimidazole hydrochloride.
融点242〜244°C(分解)。Melting point 242-244°C (decomposition).
元素分析値 C22H24FN30S−HCt−)H2
0に対して
計算値二C60,27、H5,86、H9,59実測値
: C60,22、H5,85、H9,63実施例 2
1−〔1−エチル−1−(3−(4−フルオロベンゾイ
ル)プロピルシー4−ピペリジルコ−2−メルカプトベ
ンズイミダゾールヨウ化物550■を80〜のカリウム
と20m1の第三級ブタノールの溶液に加え、攪拌下2
時間加熱還流する。Elemental analysis value C22H24FN30S-HCt-)H2
Calculated value for 0 2 C60,27, H5,86, H9,59 Actual value: C60,22, H5,85, H9,63 Example 2 1-[1-ethyl-1-(3-(4- 550 μl of 4-piperidyl-2-mercaptobenzimidazole iodide were added to a solution of 80 μl of potassium and 20 ml of tert-butanol and stirred for 2 hours.
Heat to reflux for an hour.
反応後溶媒留去、10%−炭酸ナトリウム水溶液を加え
50m1のクロロホルム3回抽出。After the reaction, the solvent was distilled off, a 10% aqueous sodium carbonate solution was added, and the mixture was extracted with 50 ml of chloroform three times.
無水硫酸ナトリウムで乾燥し、濃縮する。Dry over anhydrous sodium sulfate and concentrate.
析出物を濾取、アセトンより再結晶すると1−(1−〔
3−(4−フルオロベンゾイル)プロピルシー4−ピペ
リジルコ−2−メルカプトベンズイミダゾールの無色の
結晶を得る。The precipitate was collected by filtration and recrystallized from acetone.
Colorless crystals of 3-(4-fluorobenzoyl)propyl-4-piperidyl-2-mercaptobenzimidazole are obtained.
融点201〜203℃。水晶の赤外線吸収スペクトル(
KBr錠剤法)は実施例1で得た遊離塩基のそれと完全
に一致した。Melting point: 201-203°C. Infrared absorption spectrum of crystal (
KBr tablet method) was completely consistent with that of the free base obtained in Example 1.
実施例 3
1−〔1−ベンジル−1−(3−(4−フルオロベンソ
イル)フロビル〕−4−ピペリジル〕−2−メルカプト
ベンズイミダゾールヨウ化物より実施例2と同様に反応
、処理すれば、1−(1−(3−(4−フルオロベンゾ
イル)プロピル〕=4ーピペリジル〕−2−メルカプト
ベンズイミダゾールの無色結晶を得る。Example 3 If 1-[1-benzyl-1-(3-(4-fluorobenzoyl)furobyl]-4-piperidyl]-2-mercaptobenzimidazole iodide is reacted and treated in the same manner as in Example 2, Colorless crystals of 1-(1-(3-(4-fluorobenzoyl)propyl)=4-piperidyl]-2-mercaptobenzimidazole are obtained.
融点201〜203℃。水晶の赤外線吸収スペクトル(
KBr錠剤法)は実施例2で得たもののそれと完全に一
致した。Melting point: 201-203°C. Infrared absorption spectrum of crystal (
KBr tablet method) was completely consistent with that obtained in Example 2.
実施例 4
1−〔1−エチル−1−(3−(4−フルオロベンゾイ
ル)プロピルシー4−ピペリジルコ−2−メチルチオベ
ンズイミダゾール・エチレンケタールヨウ化物612〜
を80即のカリウムと20m1の第三級ブタノールの溶
液に加え、攪拌下2時間加熱還流する。Example 4 1-[1-ethyl-1-(3-(4-fluorobenzoyl)propyl-4-piperidylco-2-methylthiobenzimidazole ethylene ketal iodide 612~
was added to a solution of 80 molar potassium and 20 ml of tertiary butanol, and the mixture was heated under reflux for 2 hours with stirring.
反応後濃縮、−担メタノール中塩酸酸性とし10分間還
流する。After the reaction, the mixture was concentrated, acidified with hydrochloric acid in supported methanol, and refluxed for 10 minutes.
後10%ー炭酸ナトリウム水溶液を加え50mA’のク
ロロホルム3回抽出。Then, add 10% aqueous sodium carbonate solution and extract with chloroform at 50 mA' three times.
無水硫酸ナトリウムで乾燥し、濃縮する。析出物を濾取
、エーテルから再結晶すると1−(1−(3−(4−フ
ルオロベンゾイル)プロピル〕−4−ピペリジル〕−2
−メチルチオベンズイミダゾールの無色の結晶を得る。Dry over anhydrous sodium sulfate and concentrate. The precipitate was collected by filtration and recrystallized from ether to give 1-(1-(3-(4-fluorobenzoyl)propyl)-4-piperidyl]-2
- Colorless crystals of methylthiobenzimidazole are obtained.
融点98〜985℃。Melting point 98-985°C.
元素分析値 C23H26FN30S
計算値:C67,12,H6,37、N10.21実測
値: C67,30,H6,36,N10.26実施例
5
1−〔1−エチル−1−(3−(4−フルオロベンゾイ
ル)プロピルシー4−ピペリジルシー2−メルカプトベ
ンズイミダゾール・エチレンケクールアセテート530
1n9をキシレン10m1およびアセトニl−IJル2
mlの溶液に加え、攪拌下48時間加熱還流する。Elemental analysis value C23H26FN30S Calculated value: C67,12, H6,37, N10.21 Actual value: C67,30, H6,36, N10.26 Example 5 1-[1-ethyl-1-(3-(4- fluorobenzoyl) propylcy 4-piperidylycy 2-mercaptobenzimidazole ethylene kecool acetate 530
1n9 in 10ml of xylene and 2ml of acetonyl
ml of solution and heated under reflux for 48 hours while stirring.
反応後溶媒留去、−担メタノールに溶解し、塩酸酸性に
て10分間還流する。After the reaction, the solvent was distilled off, the solution was dissolved in methanol and refluxed for 10 minutes under acidic hydrochloric acid.
後10%−炭酸ナトリウム水溶液を加え、50m1のク
ロロホルム3回抽出。Then, 10% aqueous sodium carbonate solution was added and extracted three times with 50 ml of chloroform.
無水硫酸ナトリウムで乾燥し、濃縮する。Dry over anhydrous sodium sulfate and concentrate.
析出物を濾取、アセトンより再結晶すると1−(1−〔
3−(4−フルオロベンゾイル)フロビルシー4−ピペ
リジルシー2−メルカプトベンズイミダゾールの無色の
結晶を得る。The precipitate was collected by filtration and recrystallized from acetone.
Colorless crystals of 3-(4-fluorobenzoyl)furobylcy, 4-piperidylycy, 2-mercaptobenzimidazole are obtained.
融点201〜203℃。Melting point: 201-203°C.
水晶の赤外線吸収スペクトル(KBr錠剤法)は実施例
1で得た遊離塩基のそれと完全に一致した3実施例 6
実施例1に準じて次の化合物が得られる。The infrared absorption spectrum (KBr tablet method) of the crystal completely matched that of the free base obtained in Example 1.3 Example 6 The following compound was obtained according to Example 1.
1)2−エチルチオ−1−(1−(3−(4−フルオロ
ベンゾイル)プロピル)−4−ピペリジルコベンズイミ
ダゾール塩酸塩;無色結晶、メタノールから再結晶、融
点210〜211°C(分解)。1) 2-Ethylthio-1-(1-(3-(4-fluorobenzoyl)propyl)-4-piperidylcobenzimidazole hydrochloride; colorless crystals, recrystallized from methanol, mp 210-211°C (decomposition).
2)2−シアノメチルチオ−1−(1−[3−(4−フ
ルオロベンゾイル)フロビル)−4−ピペリジルコベン
ズイミダゾール塩酸塩;無色結晶、メタノール−エタノ
ールの混液から再結晶、融点201〜202.5°C(
分解)。2) 2-cyanomethylthio-1-(1-[3-(4-fluorobenzoyl)furovir)-4-piperidylcobenzimidazole hydrochloride; colorless crystals, recrystallized from a methanol-ethanol mixture, melting point 201-202. 5°C (
Disassembly).
3) 1−(1−C3−(4−フルオロベンシイノリ
プロピル〕−4−ピペリジル)−2−7”ロバルギルチ
オベンズイミダゾールジ塩酸塩;無色結晶、エタノール
−アセトンの混液から再結晶、融点156〜158°C
(分解)。3) 1-(1-C3-(4-fluorobencyinolipropyl)-4-piperidyl)-2-7” lovargylthiobenzimidazole dihydrochloride; colorless crystals, recrystallized from a mixture of ethanol and acetone, melting point 156 ~158°C
(Disassembly).
4) 1−(1−(3−(4−フルオロベンゾイル)
プロピルシー4−ピペリジルコ−2−インプロピルチオ
ベンズイミダゾール臭化水素酸塩;無色鱗片状晶、クロ
ロホルム−エタノールの混液から再結晶、融点222〜
224.5°C(分解)。4) 1-(1-(3-(4-fluorobenzoyl)
Propylcy 4-piperidylco-2-inpropylthiobenzimidazole hydrobromide; colorless scaly crystals, recrystallized from a chloroform-ethanol mixture, melting point 222~
224.5°C (decomposition).
実施例 7 実施例2に準じて次の化合物が得られる。Example 7 According to Example 2, the following compound is obtained.
1) 1−CI−C3−(4−フルオロベンゾイル)
プロピルシー4−ピペリジル〕−2−ヒドロキシエチル
チオベンズイミダゾール:無色プリズム晶、アセトン−
エーテルの混液から再結晶、融点103〜104°C8
2) 1−(1−C4,4−ビス(4−フルオロフェ
ニル)フチル〕−4−ピペリジル〕−2−メルカプトベ
ンズイミダゾール;無色プリズム晶、エーテルから再結
晶、融点224〜227℃。1) 1-CI-C3-(4-fluorobenzoyl)
Propylcy 4-piperidyl]-2-hydroxyethylthiobenzimidazole: colorless prismatic crystals, acetone-
Recrystallized from a mixture of ether, melting point 103-104°C8 2) 1-(1-C4,4-bis(4-fluorophenyl)phthyl]-4-piperidyl]-2-mercaptobenzimidazole; colorless prismatic crystals, ether Recrystallized from, melting point 224-227°C.
3) 1−〔1−(4,4−ビス(4−フルオロフェ
ニル)フチル〕−4−ピペリジル)−2−メチルチオベ
ンズイミダゾール;無色プリズム晶、エーテル−ノルマ
ルヘキサンの混液から再結晶、融点110.5〜111
.5℃。3) 1-[1-(4,4-bis(4-fluorophenyl)phthyl]-4-piperidyl)-2-methylthiobenzimidazole; colorless prism crystals, recrystallized from a mixture of ether-n-hexane, melting point 110. 5-111
.. 5℃.
4)2−ベンジルチオ−1−(1−(3−(4−フルオ
ロベンゾイル)プロピル〕−4−ピペリジル〕ベンズイ
ミダゾール;無色プリズム晶、クロロホルム−エーテル
の混液から再結晶、融点124〜126℃。4) 2-Benzylthio-1-(1-(3-(4-fluorobenzoyl)propyl]-4-piperidyl)benzimidazole; colorless prism crystals, recrystallized from a chloroform-ether mixture, melting point 124-126°C.
5) 1−(1−C3−(4−フルオロベンゾイル)
プロピルシー4−ピペリジルクー2−パラクロルフェナ
シルチオベンズイミダゾール・ハイドレート;無色針状
晶、ベンセンから再結晶、融点68〜70℃。5) 1-(1-C3-(4-fluorobenzoyl)
Propyl-4-piperidyl-2-parachlorophenacilthiobenzimidazole hydrate; colorless needle crystals, recrystallized from benzene, melting point 68-70°C.
6) 1−(1−(3−(4−フルオロベンゾイル)
プロピルシー4−ピペリジル)−2−(2−二トロフェ
ニルチオ)ベンズイミダゾール;黄色結晶、エタノール
から再結晶、融点124〜127℃。6) 1-(1-(3-(4-fluorobenzoyl)
Propyl (4-piperidyl)-2-(2-nitrophenylthio)benzimidazole; yellow crystals, recrystallized from ethanol, mp 124-127°C.
Claims (1)
一基、カルボニル基或は保護されたカルボニル基を、R
1は水素原子、直鎖状もしくは分枝状低級アルキル基、
アラルキル基、ベンゾイル低級アルキル基、シアノ低級
アルキル基、低級アルキル基、アリール基或はヒドロキ
シ低級アルキル基を、鳥はアルキル基或はアラルキル基
を、X−はアニオンを示す。 )であられされるピペリジニウム塩を加熱するかもしく
は塩基で処理し、必要に応じて加水分解することを特徴
とする一般式 (式中Qは−CH(Ar)−基又はカルボニル基を、A
r、R1は前記に同じ。 )で示されるピペリジルベンズイミダゾール誘導体又は
その塩類の製法。[Claims] 1 General formula (wherein Ar represents a halophenyl group, Ql represents -CH(Ar)
one group, a carbonyl group or a protected carbonyl group, R
1 is a hydrogen atom, a linear or branched lower alkyl group,
An aralkyl group, a benzoyl lower alkyl group, a cyano lower alkyl group, a lower alkyl group, an aryl group or a hydroxy lower alkyl group, a bird represents an alkyl group or an aralkyl group, and X- represents an anion. ) is heated or treated with a base and optionally hydrolyzed.
r and R1 are the same as above. ) A method for producing a piperidylbenzimidazole derivative or a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50061608A JPS5811871B2 (en) | 1975-05-23 | 1975-05-23 | Piperidylbenzimidazole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50061608A JPS5811871B2 (en) | 1975-05-23 | 1975-05-23 | Piperidylbenzimidazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS51136673A JPS51136673A (en) | 1976-11-26 |
| JPS5811871B2 true JPS5811871B2 (en) | 1983-03-04 |
Family
ID=13176039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50061608A Expired JPS5811871B2 (en) | 1975-05-23 | 1975-05-23 | Piperidylbenzimidazole |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5811871B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY150602A (en) * | 2007-08-31 | 2014-01-30 | Purdue Pharma Lp | Subtituted-quinoxaline-type piperidine compounds and the uses thereof |
-
1975
- 1975-05-23 JP JP50061608A patent/JPS5811871B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS51136673A (en) | 1976-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2705446C2 (en) | ||
| JPS6012350B2 (en) | Method for producing novel arylpiperidine derivatives | |
| ES2607842T3 (en) | Procedure for producing certain 2- (pyridin-3-yl) thiazoles | |
| JPH02268158A (en) | Heterocyclic cycloalkane, its production and pharmaceutical composite containing that cycloalkane for disease or symptom mediated by leukotrien | |
| TRACY et al. | Studies in the Pyridine Series. II. Synthesis of 2-Methyl-3-(β-Hydroxyethyl) pyridine and of the pyridine analog of thiamine (vitamin B1) | |
| Harvill et al. | Haloalkyltetrazole and aminoalkyltetrazole derivatives | |
| JPS60215668A (en) | Substituted iminophenol compound | |
| EP0592664A1 (en) | Novel diphenylthyazole derivative | |
| JPS5811871B2 (en) | Piperidylbenzimidazole | |
| JPS5823398B2 (en) | Piperidylbenzimidazole | |
| JPS59512B2 (en) | Pyrazole -5- Onkagobutsuno Seizouhouhou | |
| Djerassi et al. | The Reaction of α-Halo Ketones with 2-Pyridinethiol1 | |
| US3963727A (en) | 1,2 Disubstituted benzimidazole derivatives | |
| JPS63165362A (en) | Substituted aminomethyl-5, 6, 7, 8- tetrahydronaphthyloxyacetic acids, intermediates, production thereof and their use in medicine | |
| TW204347B (en) | ||
| Das et al. | A new approach to synthesis of dihalogenated 8-quinolinol derivatives | |
| EP0000013B1 (en) | 4-phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing them and process for preparation of these compositions | |
| JPS5825677B2 (en) | 3-tetrazole-1-azaxanthone derivative and method for producing the same | |
| JPS5817461B2 (en) | Method for producing butyrophenone derivatives | |
| JPH0710863B2 (en) | Novel derivative of 4-OH quinolinecarboxylic acid substituted at position 2 with an etherifiable or esterifiable dihydroxy group, a process for its preparation and its use as a medicament | |
| JPS5811873B2 (en) | Piperidylbenzimidazole | |
| JPS6353984B2 (en) | ||
| CN112047962A (en) | 2H-thiazolo[3,2-b]-1,2,4-triazine-3,7-dione derivatives and their applications | |
| JPS6141915B2 (en) | ||
| JPH0357896B2 (en) |